The Motley Fool·Apr 21·Stefon WaltersSmall-Cap Rally: Why $VTWO Deserves Portfolio Consideration$VTWO offers low-cost small-cap exposure with 0.06% fees, outperforming $SPY year-to-date amid economic recovery prospects. NVDAVTWOgrowth opportunityportfolio diversification
The Motley Fool·Mar 22·Rick OrfordIREN's AI Infrastructure Bet: Dilution Risk or Growth Opportunity?IREN's AI infrastructure capital raise triggers shareholder dilution concerns but may present buying opportunity if management executes expansion successfully. IRENgrowth opportunityAI infrastructure
The Motley Fool·Mar 5·Keith NoonanTesla Bets Company Future on Robotics While Core EV Business StumblesTesla shifts focus to robotaxis and humanoid robots amid declining vehicle sales and earnings. Massive upside potential offset by execution risks and stretched valuation. MSMSpAMSpEMSpFMSpI+6growth opportunityexecution risk
The Motley Fool·Mar 1·Reuben Gregg BrewerMedtronic's FDA-Approved Hugo Robot Could Unlock Major Growth as Valuation Gap WidensMedtronic ($MDT) wins FDA approval for Hugo surgical robot, trading at 27x P/E versus competitor Intuitive Surgical ($ISRG) at 64x, offering potential upside with 2.9% dividend yield. MDTISRGgrowth opportunityvaluation
The Motley Fool·Feb 27·Neha ChamariaDonaldson Shares Fall 18% on Guidance Cut Despite Record Quarterly PerformanceDonaldson shares fell 18% despite record quarterly results, due to lowered full-year guidance citing weak trucking and aerospace demand. Company announced $820M acquisition to diversify revenue. DCIstock declineacquisition